Sibiriline, a novel dual inhibitor of necroptosis and ferroptosis, prevents RIPK1 kinase activity and (phospho)lipid peroxidation as a potential therapeutic strategy | Cell Death Discovery
This story is reported by Nature. Read what other outlets are saying below, then open the original report for full details.